NCT02271711View on ClinicalTrials.gov

Expanded Natural Killer Cell Infusion in Treating Younger Patients With Recurrent/Refractory Brain Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

March 17, 2015

Primary Completion Date

August 28, 2020

Study Completion Date

August 28, 2020

Conditions
Recurrent Childhood MedulloblastomaRecurrent EpendymomaRecurrent Medulloblastoma
Interventions
OTHER

Laboratory Biomarker Analysis

Correlative studies

BIOLOGICAL

Natural Killer Cell Therapy

Given autologous ex-vivo expanded NK cells IV

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT02271711 - Expanded Natural Killer Cell Infusion in Treating Younger Patients With Recurrent/Refractory Brain Tumors | Biotech Hunter | Biotech Hunter